Baxter, Momenta enter into deal on biosimilars
Baxter, Momenta enter into deal on biosimilars Reuters
View ArticleMomenta Pharma partnership with Baxter positive, says Leerink
Momenta Pharma partnership with Baxter positive, says Leerink TheFlyOnTheWall
View ArticleMomenta tumbles on Lovenox court ruling
Momenta tumbles on Lovenox court ruling Marketwatch
View Article5 Overlooked Healthcare Stocks To Consider Now
5 Overlooked Healthcare Stocks To Consider Now Seeking Alpha
View Article4 Compelling Alternatives To Vertex Pharma
4 Compelling Alternatives To Vertex Pharma Seeking Alpha
View Article20 Biotech Stocks Being Bought Up By Hedge Funds
20 Biotech Stocks Being Bought Up By Hedge Funds Seeking Alpha
View ArticleMomenta Pharmaceuticals Announces Decision in Teva Patent Litigation
Momenta Pharmaceuticals Announces Decision in Teva Patent Litigation Yahoo/GlobeNewsWire
View ArticleTeva Jumps Most Since 2000 On Copaxone Ruling In U.S.
Teva Jumps Most Since 2000 On Copaxone Ruling In U.S. Bloomberg
View ArticleEven With Teva's Patent Ruling, The Company Is Only Covered Until 2015
Even With Teva's Patent Ruling, The Company Is Only Covered Until 2015 Seeking Alpha
View ArticlePluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now?
Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now? Seeking Alpha
View ArticleMomenta Pharmaceuticals Acknowledges Federal Circuit Opinion Supporting Order...
Momenta Pharmaceuticals Acknowledges Federal Circuit Opinion Supporting Order Issued January 26, 2012 in Ongoing Suit Against Amphastar Pharmaceuticals and Watson Pharmaceuticals Yahoo/GlobeNewsWire
View ArticleMomenta Loses In Appeals Court Over Watson’s Lovenox Copy
Momenta Loses In Appeals Court Over Watson’s Lovenox Copy Bloomberg
View Article4 Small-Cap Biotech Stocks Generating Profits With Buy Ratings
4 Small-Cap Biotech Stocks Generating Profits With Buy Ratings Seeking Alpha
View Article2012 Biotech Stock Predictions: An Interim Report Card
2012 Biotech Stock Predictions: An Interim Report Card TheStreet.com
View ArticleThe Worst of 2012: Momenta Pharmaceuticals
The Worst of 2012: Momenta Pharmaceuticals Motley Fool
View Article3 Things to Watch at Momenta Pharmaceuticals
3 Things to Watch at Momenta Pharmaceuticals Motley Fool
View ArticleMomenta Pharmaceuticals sticks to guidance despite revenue plunge
Momenta Pharmaceuticals sticks to guidance despite revenue plunge bizjournals
View ArticleMomenta pleads for Supreme Court review in Lovenox generic case
Momenta pleads for Supreme Court review in Lovenox generic case Fierce Pharma
View Article
